USA Rare Earth Sits on $1.5 Billion in Cash and Almost No Revenue. Here's How to Value That

USA Rare Earth held about $1.53B in cash while generating just $5.8M of quarterly revenue, yet is attempting to reposition as a critical-minerals supplier tied to the U.S. China-shift in sourcing. The company agreed to acquire Brazil’s Serra Verde for ~$2.8B (paying $300M cash and issuing ~126.5M shares), with a DOD-backed structure that could support Serra Verde to reach $550M–$650M annualized EBITDA by end-2027 and ~$1.8B EBITDA in 2030. The planned step-change in scale is a clear catalyst, but near-term economics remain weak and the equity issuance is meaningfully dilutive.

Analysis

USAR is less a conventional mining equity than a state-backed call option on a strategic supply-chain rebuild. That makes the stock’s main driver per-share dilution and execution speed, not near-term sales, so the market should probably value it closer to a multi-year project finance story than a commodity producer. The implication is that every incremental dollar of capital raised may matter more than the next quarter’s revenue, because the base case is still a long runway before meaningful free cash flow.

The immediate winners from this policy arc are the liquid peers and downstream users that can monetize de-risking without taking construction risk. MP Materials is the cleanest public proxy, while defense primes and magnet-dependent industrials benefit from lower supplier concentration if USAR/DoD funding actually translates into domestic or allied capacity. The second-order loser is any investor assuming scarcity alone creates equity upside; if alternative non-China supply grows, the premium for “strategic optionality” can compress before the asset base is fully built.

The key catalyst path is binary over the next 1-3 months: deal close, financing details, and evidence that the combined asset can hit throughput assumptions. Over 6-18 months, the real risk is that dilution and capex absorption outrun operational progress, especially if rare-earth pricing softens or policy support becomes more selective. The contrarian miss is that government sponsorship reduces insolvency risk but does not guarantee attractive per-share returns; the equity can still underperform if the market re-rates the project at a lower probability of hitting far-dated EBITDA targets.

Key Decisions for Investors

• Prefer MP over USAR as the cleaner 1-3 month expression of U.S. rare-earth de-risking; long MP / short USAR as a pair trade, targeting 15-25% relative outperformance if dilution and execution concerns keep USAR volatile. Stop if USAR closes the deal cleanly and begins issuing credible near-term volume guidance.
• Do not chase USAR common stock ahead of the next financing/closing milestone; if exposure is required, use a small 12-24 month call spread only after dilution terms are locked and integration milestones are disclosed. Risk/reward is acceptable only if the market is paying for optionality, not operating earnings.
• Set a watch item on rare-earth oxide pricing and any change in government procurement cadence; if the commodity backdrop weakens or public support slows, the 2027-2030 EBITDA narrative can de-rate quickly. Falsifier for the bullish thesis: missed integration milestones or another equity raise that meaningfully resets per-share economics.